SEC Form 13F
| Report period | 2026-06-30 |
|---|---|
| Publicly available | 2026-08-15 |
| Reported value | $6,870,469,447 |
| Positions | 67 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| GUARDANT HEALTH INC | GH | COM | $509,098,599 | 3,393,312 |
| IMMUNOVANT INC | IMVT | COM | $359,914,548 | 9,341,151 |
| STRUCTURE THERAPEUTICS INC | GPCR | SPONSORED ADS | $254,399,664 | 4,740,072 |
| VAXCYTE INC | PCVX | COM | $249,959,000 | 4,300,000 |
| ALNYLAM PHARMACEUTICALS INC | ALNY | COM | $248,349,750 | 825,000 |
| VERADERMICS INC | MANE | COMMON STOCK | $245,880,000 | 2,000,000 |
| TARSUS PHARMACEUTICALS INC | TARS | COM | $230,786,378 | 3,666,768 |
| NUVALENT INC | NUVL | COM | $220,240,267 | 1,783,322 |
| ALKERMES PLC | ALKS | SHS | $209,580,000 | 4,000,000 |
| OCULAR THERAPEUTIX INC | OCUL | COM | $193,319,289 | 19,686,282 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.